Business Description
Polynovo Ltd
NAICS : 325413
SIC : 2835
ISIN : AU000000PNV0
Description
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.77 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | 1.88 | |||||
| Interest Coverage | 15.23 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 16.33 | |||||
| Beneish M-Score | -1.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 49.5 | |||||
| 3-Year Book Growth Rate | 45.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 81.25 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 24.07 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.32 | |||||
| 9-Day RSI | 7.04 | |||||
| 14-Day RSI | 19.27 | |||||
| 3-1 Month Momentum % | -10 | |||||
| 6-1 Month Momentum % | -14.45 | |||||
| 12-1 Month Momentum % | -3.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.46 | |||||
| Quick Ratio | 2.84 | |||||
| Cash Ratio | 1.34 | |||||
| Days Inventory | 791.53 | |||||
| Days Sales Outstanding | 74.49 | |||||
| Days Payable | 821.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.4 | |||||
| Shareholder Yield % | -0.06 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 96.01 | |||||
| Operating Margin % | 6.09 | |||||
| Net Margin % | 5.11 | |||||
| FCF Margin % | -13.77 | |||||
| ROE % | 8.18 | |||||
| ROA % | 5.56 | |||||
| ROIC % | 12.83 | |||||
| 3-Year ROIIC % | 36.12 | |||||
| ROC (Joel Greenblatt) % | 15.7 | |||||
| ROCE % | 7.88 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 158.89 | |||||
| Forward PE Ratio | 64.36 | |||||
| PE Ratio without NRI | 158.89 | |||||
| Price-to-Owner-Earnings | 178.75 | |||||
| PS Ratio | 8.67 | |||||
| PB Ratio | 13.12 | |||||
| Price-to-Tangible-Book | 12.87 | |||||
| EV-to-EBIT | 143.54 | |||||
| EV-to-EBITDA | 105.99 | |||||
| EV-to-Revenue | 8.43 | |||||
| EV-to-Forward-Revenue | 9.04 | |||||
| EV-to-FCF | -59.6 | |||||
| Price-to-GF-Value | 0.31 | |||||
| Price-to-Graham-Number | 10.01 | |||||
| Price-to-Net-Current-Asset-Value | 22.53 | |||||
| Earnings Yield (Greenblatt) % | 0.7 | |||||
| FCF Yield % | -1.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CALZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Polynovo Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 74.905 | ||
| EPS (TTM) ($) | 0.005 | ||
| Beta | 1.37 | ||
| 3-Year Sharpe Ratio | 0.49 | ||
| 3-Year Sortino Ratio | 0.92 | ||
| Volatility % | 70.58 | ||
| 14-Day RSI | 19.27 | ||
| 14-Day ATR ($) | 0.023361 | ||
| 20-Day SMA ($) | 1.10925 | ||
| 12-1 Month Momentum % | -3.57 | ||
| 52-Week Range ($) | 0.9011 - 1.82 | ||
| Shares Outstanding (Mil) | 690.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Polynovo Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Polynovo Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Polynovo Ltd Frequently Asked Questions
What is Polynovo Ltd(CALZF)'s stock price today?
The current price of CALZF is $0.90. The 52 week high of CALZF is $1.82 and 52 week low is $0.90.
When is next earnings date of Polynovo Ltd(CALZF)?
The next earnings date of Polynovo Ltd(CALZF) is 2025-08-22 Est..
Does Polynovo Ltd(CALZF) pay dividends? If so, how much?
Polynovo Ltd(CALZF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers